ARK Genomic Revolution Multi-Sector ETF (ARKG) ETF

Expense Ratio: 0.75% | AUM: 10.04M | Issuer: Ark Funds

ARKG Daily Price Range
ARKG 52-Week Price Range

ARKG - Real-Time SMART Grade™

B
Buy

Overall SMART Grade

ARKG has a real-time SMART Grade of B (Buy).

Learn More About SMART Grades™

ARKG - Profile & Info


The investment objective of the ARK Genomic Revolution Multi-Sector ETF seeks to invest in companies substantially focused on and are expected to substantially benefit from extending and enhancing the quality of human and other life by incorporating technological and scientific developments, improvements and advancements in genomics into their business. One such way this is accomplished is by offering new products or services that rely on genomic sequencing, analysis, synthesis or instrumentation. These companies may develop, produce or enable: Agricultural Biology, Bioinformatics, Bionic Medicine, DNA Sequencing, Instrumentation, Stem Cells, Pharmaceutical Innovation, Molecular Medicine and Diagnostics, and Bio-inspired Computing. The Fund is concentrated in any industry or group of industries in the health care sector, including, in particular, issuers having their principal business activities in the biotechnology industry. Other industries in the health-care sector include medical laboratories and research, drug manufacturers and agricultural chemicals.

Issuer Ark Funds
Expense Ratio 0.75%
Assets Under Management (AUM) 10.04M
Asset Class Equity
ETF Category Health & Biotech ETFs
Net Asset Value (NAV) $19.88
Options? No
Total Holdings 37

ARKG - Top Holdings

Symbol Holding Name % of Total
ILMN Illumina Inc 10.18%
FMI Foundation Medicine Inc 6.34%
CERS Cerus Corp 6.07%
CPHD Cepheid 5.39%
NVTA Invitae Corp 5.17%
ALNY Alnylam Pharmaceuticals Inc 5.02%
CGEN Compugen Ltd 4.99%
REGN Regeneron Pharmaceuticals Inc 4.15%
MON Monsanto Co 3.89%
ATHN athenahealth Inc 3.74%
MDSO Medidata Solutions Inc 3.48%
VCYT Veracyte Inc 2.56%
IONS IONIS PHARMACEUTICALS INC 2.37%
GILD Gilead Sciences Inc 2.19%
NSTG NanoString Technologies Inc 2.14%
BIIB Biogen Inc 2.14%
BLUE Bluebird Bio Inc 2.09%
MCRB Seres Therapeutics Inc 2.01%
KITE Kite Pharma Inc 1.97%
NVDA NVIDIA Corp 1.94%
TMO Thermo Fisher Scientific Inc 1.92%
XON Intrexon Corp 1.92%
NLNK NewLink Genetics Corp 1.90%
NVS Novartis AG 1.89%
BMY Bristol-Myers Squibb Co 1.88%
FPRX Five Prime Therapeutics Inc 1.81%
QURE uniQure NV 1.58%
MTD Mettler-Toledo International Inc 1.47%
INCY Incyte Corp 1.39%
AGIO Agios Pharmaceuticals Inc 1.36%
CELG Celgene Corp 1.05%
BMRN BioMarin Pharmaceutical Inc 1.04%
JNJ Johnson & Johnson 1.01%
NVZMY Novozymes A/S 1.00%
EVGN Evogene Ltd 0.66%
IMDZ Immune Design Corp 0.20%
0.00%

ARKG - Price/Volume Stats

Current price $20.07
Prev. close $19.87
Day low $20.00
Day high $20.09
52-week high $20.88
52-week low $15.85
Day Volume 1,300
Avg. volume 3,953
Dividend yield N/A

ARKG - Recent Returns

1-mo 6.76%
3-mo 14.03%
6-mo -0.69%
1-year N/A
3-year N/A
5-year N/A
YTD 18.55%
2016 -19.23%
2015 -1.27%
2014 N/A
2013 N/A
2012 N/A

ARKG - Stock Chart


Page generated in 2.2738 seconds.